Envista Holdings Corp

This committee provides the official revenue estimates and technical analysis for all tax legislation. Its expert input directly shapes corporate tax policy, capital investment credits, and the overall tax burden, which significantly impacts Envista's financial performance.

This committee controls taxation, trade, and entitlement spending (e.g., Medicare/Medicaid). Its decisions on corporate tax rates, import/export tariffs, and reimbursement policies for dental-related services within federal programs directly impact Envista's profitability and market conditions.

This committee allocates specific federal spending, directly determining the cash flow for government healthcare programs (e.g., VA, NIH research) that procure dental equipment or fund relevant R&D, thus directly impacting a significant market segment for Envista.

This committee directly regulates the FDA, which is the primary regulatory body for medical devices like dental equipment and supplies. Its decisions on product approval, safety standards, and labor laws directly impact Envista's operations and market access.

This committee's oversight of antitrust laws directly impacts potential mergers and acquisitions in the industry, and its role in intellectual property protection (patents) is critical for a manufacturing company like Envista with proprietary products.

This committee oversees the Department of Veterans Affairs, which is a major provider of healthcare services, including dental care. Its funding decisions directly impact procurement of dental equipment and supplies, creating a direct market for Envista's products.